Stock Screener App
Frei
-
Play Store
App Store
Installieren
Installieren
Dark
DE
Sign in
Beobachtungsliste
Top-Listen
Märkte
Neu
Kryptos
Branchen
Elite
Marktsimulator
SABS
$2.99
1.70%
0.05
Sab Biotherapeutics Inc (SABS)
Indikator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Überblick
Nachrichten
Preisverlauf
Optionskette
Finanzen
Forum
Prognose
Aktiensplit
Ähnlich wie SABS
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
In EDGAR öffnen
|
In Reuters öffnen
Finanzdaten der Sab Biotherapeutics Inc-Aktie (SABS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Periodenlänge
3 Monate
3 Monate
3 Monate
3 Monate
3 Monate
Operating Expenses
16.90%
23.38
20.00
15.77
12.68
9.73
Research and Development
20.70%
16.17
13.40
10.73
8.97
7.00
Operating Income/Loss
16.90%
-23.38
-20.00
-15.77
-12.68
-9.73
Nonoperating Income/Loss
21.51%
0.89
1.13
-1.09
58.12
-0.38
Net Income/Loss
19.20%
-22.49
-18.87
-16.86
45.45
-10.11
Attributable To Parent
19.20%
-22.49
-18.87
-16.86
45.45
-10.11
Available To Common Stockholders, Basic
19.20%
-22.49
-18.87
-2.85
5.34
-10.11
Basic Average Shares
48.91%
79.75
53.56
9.56
10.66
9.29
Diluted Average Shares
48.91%
79.75
53.56
31.04
77.86
9.29
Basic Earnings Per Share
20.00%
-0.28
-0.35
-0.51
0.50
-1.09
Diluted Earnings Per Share
20.00%
-0.28
-0.35
-0.46
-0.21
-1.09
